Form D · Biotechnology
Hurel Corp
Beverly Hills, CA · CIK 0001745145
Offering snapshot reported Jun 29, 2018 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 29, 2018 | Initial | Yet to sell | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-315841
n/a
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| n/a | None |
Source: Form D, filed Jun 29, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Morris Freedman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8840 Wilshire Blvd, 2 Nd Floor
Beverly Hills, CA, 90211
Beverly Hills, CA, 90211